Show simple item record

dc.contributor.authorWorld Health Organization
dc.coverage.spatialGenevaen_US
dc.date.accessioned2017-05-18T13:41:42Z
dc.date.available2017-05-18T13:41:42Z
dc.date.issued2017-04
dc.identifier.urihttps://iris.who.int/handle/10665/255487
dc.description26 p.en_US
dc.language.isoenen_US
dc.publisherWorld Health Organizationen_US
dc.rightsCC BY-NC-SA 3.0 IGOen_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/3.0/igoen_US
dc.subject.meshDrugs, Essentialen_US
dc.subject.meshSafety Managementen_US
dc.subject.meshDrug Monitoringen_US
dc.subject.meshPeriodicalen_US
dc.subject.meshPharmacovigilance
dc.titleWHO pharmaceuticals newsletter: 2017, No. 2en_US
dc.typeJournal / periodical articlesen_US
dc.rights.holderWorld Health Organizationen_US
dc.description.startpage1en_US
dc.description.endpage26en_US
dc.relation.ispartofjournalWHO pharmaceuticals newsletteren_US
dc.relation.issue2en_US


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record